Rony Kleinfeld - Elbit Med External Director
EMTC Stock | ILS 15.30 0.30 1.92% |
Director
Mr. Rony Kleinfeld serves as External Director at Elbit Medical Technologies Ltd since June 21 2010. He served as Chief Executive Officer of Maariv Publishing House Ltd and Hed Artzi Ltd. He also served as External Director at Macpel Industries Ltd Excites Ltd Gal Maaton Ltd Levi Epstein Printing Ltd Densher Ltd and Elron Real Estate Ltd since 2010.
Age | 55 |
Tenure | 14 years |
Phone | 972 3 608 6029 |
Web | http://www.elbitimaging.com |
Elbit Med Management Efficiency
Elbit Med's management efficiency ratios could be used to measure how well Elbit Med manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 11 records | DIRECTOR Age | ||
Sanford Zweifach | Compugen | 60 | |
Michal Preminger | Compugen | N/A | |
Joshua Shemer | Compugen | 63 | |
Dov Hershberg | Compugen | 74 | |
Eran Perry | Compugen | N/A | |
Arie Ovadia | Compugen | 67 | |
Ruth Arnon | Compugen | 86 | |
Gilead Halevy | Compugen | 51 | |
JeanPierre Bizzari | Compugen | 64 | |
Kinneret Savitsky | Compugen | 50 | |
Yair Aharonowitz | Compugen | 73 |
Management Performance
Return On Equity | 0.0237 | |||
Return On Asset | -0.0038 |
Elbit Med Tech Leadership Team
Elected by the shareholders, the Elbit Med's board of directors comprises two types of representatives: Elbit Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elbit. The board's role is to monitor Elbit Med's management team and ensure that shareholders' interests are well served. Elbit Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elbit Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tsipi Siani, Chief Officer | ||
BA LLB, Chairman CEO | ||
Valery Kogan, CFO | ||
Rony Kleinfeld, External Director | ||
Yael Naftali, Vice President - Finance | ||
Vered Sharvit, External Director | ||
Ron Kleinfeld, External Director | ||
Nir Mendelboim, External Director | ||
Jacob Vortman, | ||
Maurice Ferre, CEO of InSightec Ltd | ||
Ron Hadassi, Chairman of the Board | ||
Doron Moshe, Deputy CFO | ||
Tsipora Amossi, Vice President - Finance | ||
Galia Malcha, Director | ||
Stuart Hershkowitz, Director |
Elbit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elbit Med a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0237 | |||
Return On Asset | -0.0038 | |||
Profit Margin | 0.51 % | |||
Operating Margin | (0.25) % | |||
Current Valuation | 46.83 M | |||
Shares Outstanding | 92.79 M | |||
Shares Owned By Insiders | 84.51 % | |||
Price To Book | 0.63 X | |||
Price To Sales | 0.71 X | |||
Gross Profit | 135.14 M |
Pair Trading with Elbit Med
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elbit Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elbit Med will appreciate offsetting losses from the drop in the long position's value.Moving together with Elbit Stock
0.91 | BOLT | BioLight Life Sciences | PairCorr |
Moving against Elbit Stock
0.86 | PSTI | Pluristem | PairCorr |
0.65 | GPGB | GP Global Power | PairCorr |
0.6 | PRTC | Priortech | PairCorr |
0.57 | AQUA | Aquarius Engines | PairCorr |
0.5 | APLP | Apollo Power | PairCorr |
The ability to find closely correlated positions to Elbit Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elbit Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elbit Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elbit Med Tech to buy it.
The correlation of Elbit Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elbit Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elbit Med Tech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elbit Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elbit Med Tech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Elbit Stock analysis
When running Elbit Med's price analysis, check to measure Elbit Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elbit Med is operating at the current time. Most of Elbit Med's value examination focuses on studying past and present price action to predict the probability of Elbit Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elbit Med's price. Additionally, you may evaluate how the addition of Elbit Med to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stocks Directory Find actively traded stocks across global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |